EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Efficacy of Eosin B as a New Antimalarial Drug in a Murine Model

Zahra Zamani, Alireza Sadeghi Tafreshi, Hossein Nahrevanian, Behzad Lame-Rad, Fatemeh Pourfallah, Hossein Eslamifar, Sedigheh Sadeghi, Farideh Vahabi, Ayda Iravani, Mohammad Arjmand

Malaria Research and Treatment · 2012

DOI: 10.1155/2012/381724 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Malaria Research and Treatment, 2012. Verfasst von Zahra Zamani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Pasteur Institute of Iran, Tehran 1316943551, Iran. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Institut Pasteur.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The initial success of any adopted anti-infective strategy to malaria is followed by a descent due to the emergence of resistance to it. The search for new drugs and drug targets is a consistent demand in this disease. Eosin B, a common laboratory dye, is reported to have good antiparasitic properties in vitro . It was studied for its antiparasitic effect in vivo on chloroquine-sensitive Plasmodium berghei murine malaria. Eosin B was administered in 2 different doses by either the oral or parenteral route, once or twice daily to mice infected with Plasmodium berghei . Both the doses of eosin B 400 mg/kg and 800 mg/kg gave better results than the controls which were 40 mg/kg chloroquine and 100 mg/kg of arteether with P < 0 . 005 significance. Percentage suppressive activity by Peter’s test of eosin B was better, though at a higher dose than both the controls. Survival rate of mice receiving the higher dose of eosin B was longer than that of the controls. When administered twice daily, the mice were fully cured after 4 days. Eosin B seems to be a promising drug exhibiting good antimalarial effects in the murine model of the disease.

Autor:innen und Institutionen

  • Department of Biochemistry, Pasteur Institute of Iran, Tehran 1316943551, Iran.

Förderung

  • Institut Pasteur

Zitieren

APA

Zamani, Z., Tafreshi, A. S., Nahrevanian, H., Lame-Rad, B., Pourfallah, F., Eslamifar, H., Sadeghi, S., Vahabi, F., Iravani, A., & Arjmand, M. (2012). Efficacy of Eosin B as a New Antimalarial Drug in a Murine Model. Malaria Research and Treatment. https://doi.org/10.1155/2012/381724

Vancouver

Zamani Z, Tafreshi AS, Nahrevanian H, Lame-Rad B, Pourfallah F, Eslamifar H, et al. Efficacy of Eosin B as a New Antimalarial Drug in a Murine Model. Malaria Research and Treatment. 2012. doi:10.1155/2012/381724

BibTeX
@article{Zamani2012,
  author = {Zamani, Zahra and Tafreshi, Alireza Sadeghi and Nahrevanian, Hossein and Lame-Rad, Behzad and Pourfallah, Fatemeh and Eslamifar, Hossein and Sadeghi, Sedigheh and Vahabi, Farideh and Iravani, Ayda and Arjmand, Mohammad},
  title = {Efficacy of Eosin B as a New Antimalarial Drug in a Murine Model},
  journal = {Malaria Research and Treatment},
  year = {2012},
  doi = {10.1155/2012/381724}
}
Kostenlos starten →